LPL and B-cell chronic lymphocytic leukemia: Aberrant promoter DNA methylation changes have been established in CLL, resulting in silencing of tumor suppressor genes (e.g. Wnt pathway regulators) and reactivation of genes involved in apoptosis, cell proliferation and prognostic markers (e.g. NFATc1 and LPL).